News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
488,465 Results
Type
Article (8205)
Company Profile (142)
Press Release (480117)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (167341)
Career Advice (306)
Deals (25810)
Drug Delivery (7)
Drug Development (53609)
Employer Resources (14)
FDA (9783)
Job Trends (8601)
News (239447)
Policy (17960)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (507)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (100)
Alliances (33341)
ALS (112)
Alzheimer's disease (989)
Antibody-drug conjugate (ADC) (288)
Approvals (10440)
Artificial intelligence (339)
ASCO (161)
Autoimmune disease (222)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6981)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (1)
Bladder cancer (140)
Brain cancer (35)
Breast cancer (523)
Cancer (3852)
Cardiovascular disease (227)
Career advice (247)
Career pathing (1)
CAR-T (178)
CDC (1)
CDMO (19)
Celiac Disease (1)
Cell therapy (493)
Cervical cancer (35)
Clinical research (48667)
Collaboration (1298)
Commercialization (3)
Compensation (1538)
Complete response letters (36)
COVID-19 (782)
CRISPR (64)
C-suite (815)
Cystic fibrosis (87)
Data (5927)
Denatured (4)
Depression (107)
Dermatology (69)
Diabetes (358)
Diagnostics (4226)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (160)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73931)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88539)
Executive appointments (722)
FDA (12550)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (966)
Gene editing (126)
Generative AI (11)
Gene therapy (336)
GLP-1 (297)
Government (956)
Grass and pollen (3)
Guidances (281)
Healthcare (9429)
Hematology (97)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (111)
Immuno-oncology (68)
Indications (167)
Infectious disease (976)
Inflammatory bowel disease (132)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (264)
Interviews (41)
IPO (12427)
IRA (2)
Job creations (1973)
Job search strategy (237)
JPM (1)
Kidney cancer (16)
Kidney disease (46)
Layoffs (60)
Legal (5203)
Licensing (19)
Liver cancer (46)
Longevity (19)
Lung cancer (561)
Lymphoma (265)
Machine learning (29)
Management (3)
Manufacturing (573)
Marketing (8)
MASH (121)
Medical affairs (2)
Medical device (8682)
Medtech (8841)
Mergers & acquisitions (14447)
Metabolic disorders (735)
mRNA (64)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (229)
Neuropsychiatric disorders (40)
Neuroscience (1884)
NextGen: Class of 2026 (3174)
Non-profit (858)
Obesity (233)
Opinion (10)
Ovarian cancer (169)
Pain (177)
Pancreatic cancer (209)
Parkinson's disease (206)
Partnered (12)
Patents (502)
Patient recruitment (533)
Patient selection (2)
Peanut (33)
People (41550)
Peptides (3)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15777)
Phase 2 (21793)
Phase 3 (14635)
Pipeline (7788)
Policy (19)
Postmarket research (1571)
Preclinical (6659)
Press Release (34)
Prostate cancer (194)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (594)
Real estate (3030)
Recruiting (6)
Regenerative medicine (2)
Regulatory (15050)
Reports (23)
Research institute (604)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (104)
Series A (168)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2036)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (350)
Venture capital (17)
Weight loss (76)
Women's health (89)
Date
Today (70)
Last 7 days (260)
Last 30 days (1451)
Last 365 days (19186)
2026 (13815)
2025 (19365)
2024 (23126)
2023 (26707)
2022 (34791)
2021 (37389)
2020 (33619)
2019 (23359)
2018 (17566)
2017 (18878)
2016 (18103)
2015 (24451)
2014 (21782)
2013 (18177)
2012 (20251)
2011 (20447)
2010 (20351)
Location
Africa (229)
Alabama (78)
Alaska (2)
Arizona (312)
Arkansas (10)
Asia (18228)
Australia (2272)
California (12402)
Canada (3271)
China (555)
Colorado (500)
Connecticut (429)
Delaware (215)
Europe (25463)
Florida (1862)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (730)
India (51)
Indiana (324)
Iowa (16)
Japan (428)
Kansas (103)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1241)
Massachusetts (8142)
Michigan (315)
Minnesota (573)
Mississippi (4)
Missouri (82)
Montana (27)
Nebraska (11)
Nevada (123)
New Hampshire (60)
New Jersey (2707)
New Mexico (12)
New York (2914)
North Carolina (1322)
North Dakota (4)
Northern California (6223)
Ohio (296)
Oklahoma (14)
Oregon (16)
Pennsylvania (2314)
Puerto Rico (21)
Rhode Island (30)
South America (402)
South Carolina (78)
South Dakota (1)
Southern California (5177)
Tennessee (125)
Texas (2016)
United States (40225)
Utah (375)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (958)
West Virginia (1)
Wisconsin (75)
Wyoming (1)
488,465 Results for "immunotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026
August 28, 2026
·
3 min read
Press Releases
KaliVir Immunotherapeutics Announces Closing of $14 Million Series A Extension Financing
August 19, 2026
·
3 min read
Press Releases
MoonLake Immunotherapeutics Announces Proposed Public Offering
June 23, 2026
·
5 min read
Press Releases
Pinion Immunotherapeutics Publishes Preclinical Data Supporting Clinical-Ready RNA Immunotherapy for HPV-16 Cervical Precancer
August 28, 2026
·
2 min read
Press Releases
HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment
September 2, 2026
·
5 min read
Press Releases
OSE Immunotherapeutics Reports Results of its 2026 Annual General Meeting
June 24, 2026
·
2 min read
Press Releases
OSE Immunotherapeutics Evolves its Leadership Team
April 15, 2026
·
5 min read
Press Releases
HCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
August 25, 2026
·
5 min read
Press Releases
OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing
May 28, 2026
·
14 min read
Press Releases
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients
September 9, 2026
·
4 min read
1 of 48,847
Next
